CHANDAN
10 Feb 2025 - 12 Feb 2025
₹151 - ₹159
₹1,27,200
107Cr
₹5 (3.14%)
Issue open date
10 Feb 2025
Issue close date
12 Feb 2025
UPI mandate deadline
12 Feb 2025
Allotment finalization
13 Feb 2025
Refund initiation
14 Feb 2025
Share credit
14 Feb 2025
Listing date
17 Feb 2025
Mandate end date
25 Feb 2025
Lock-in end date for anchor investors (50%)
15 Mar 2025
Lock-in end date for anchor investors (remaining)
14 May 2025
Chandan Healthcare operates a large diagnostic network in North India, with extensive pathology and radiology services across Jaipur, Uttar Pradesh, and Uttarakhand. As of December 31, 2024, the company has processed over 55.79 lakh tests from about 17.11 lakh patients, mainly generating 70.04% of its revenue from Uttar Pradesh. The network includes one flagship lab, nine central labs, and various accredited centres, offering 1,496 test types. Significant revenue streams come from B2B, B2G, and B2C segments, supported by a cluster-based model for efficiency. Additionally, its subsidiary, Chandan Pharmacy Limited, enhances revenue through sales of pharmaceuticals and FMCG across 31 stores.